Envestnet Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.6M | Buy |
308,571
+11,783
| +4% | +$1.03M | 0.01% | 1234 |
|
|
2026
Q1 | $26.8M | Buy |
296,788
+38,116
| +15% | +$3.5M | 0.01% | 1150 |
|
|
2025
Q4 | $23.3M | Sell |
258,672
-83,591
| -24% | -$7.93M | 0.01% | 1116 |
|
|
2025
Q3 | $33.7M | Buy |
342,263
+19,706
| +6% | +$1.95M | 0.01% | 961 |
|
|
2025
Q2 | $29.4M | Buy |
322,557
+6,249
| +2% | +$604K | 0.01% | 1015 |
|
|
2025
Q1 | $35.8M | Buy |
316,308
+66,114
| +26% | +$7.07M | 0.01% | 865 |
|
|
2024
Q4 | $26.4M | Buy |
250,194
+49,821
| +25% | +$5.35M | 0.01% | 1019 |
|
|
2024
Q3 | $21.6M | Buy |
200,373
+51,426
| +35% | +$5.61M | 0.01% | 1131 |
|
|
2024
Q2 | $16.2M | Sell |
148,947
-37,634
| -20% | -$4.44M | 0.01% | 1253 |
|
|
2024
Q1 | $24.6M | Sell |
186,581
-25,377
| -12% | -$3.17M | 0.01% | 992 |
|
|
2023
Q4 | $25.8M | Sell |
211,958
-75,309
| -26% | -$8.4M | 0.01% | 899 |
|
|
2023
Q3 | $32.2M | Buy |
287,267
+98,977
| +53% | +$12.6M | 0.01% | 749 |
|
|
2023
Q2 | $27.4M | Buy |
188,290
+60,268
| +47% | +$8.19M | 0.01% | 773 |
|
|
2023
Q1 | $16.5M | Buy |
128,022
+11,768
| +10% | +$1.48M | 0.01% | 981 |
|
|
2022
Q4 | $14.8M | Buy |
116,254
+8,706
| +8% | +$1.01M | 0.01% | 998 |
|
|
2022
Q3 | $11.2M | Sell |
107,548
-9,626
| -8% | -$1.06M | 0.01% | 1073 |
|
|
2022
Q2 | $12.3M | Sell |
117,174
-1,436
| -1% | -$170K | 0.01% | 1043 |
|
|
2022
Q1 | $15.2M | Buy |
118,610
+26,583
| +29% | +$3.2M | 0.01% | 991 |
|
|
2021
Q4 | $11.4M | Sell |
92,027
-19,618
| -18% | -$2.57M | 0.01% | 1118 |
|
|
2021
Q3 | $15.9M | Buy |
111,645
+22,995
| +26% | +$3.38M | 0.01% | 909 |
|
|
2021
Q2 | $13.8M | Buy |
88,650
+5,683
| +7% | +$921K | 0.01% | 959 |
|
|
2021
Q1 | $12.9M | Buy |
82,967
+21,162
| +34% | +$3.28M | 0.01% | 907 |
|
|
2020
Q4 | $9.25M | Sell |
61,805
-5,443
| -8% | -$769K | 0.01% | 951 |
|
|
2020
Q3 | $8.89M | Sell |
67,248
-8,186
| -11% | -$1.07M | 0.01% | 864 |
|
|
2020
Q2 | $8.74M | Sell |
75,434
-19,414
| -20% | -$2.24M | 0.01% | 833 |
|
|
2020
Q1 | $9.31M | Buy |
94,848
+510
| +0.5% | +$66.9K | 0.01% | 710 |
|
|
2019
Q4 | $13.7M | Buy |
94,338
+1,353
| +1% | +$187K | 0.01% | 668 |
|
|
2019
Q3 | $12.4M | Buy |
92,985
+4,858
| +6% | +$628K | 0.01% | 665 |
|
|
2019
Q2 | $10.1M | Buy |
88,127
+27,253
| +45% | +$3.19M | 0.01% | 728 |
|
|
2019
Q1 | $7.55M | Buy |
60,874
+5,595
| +10% | +$636K | 0.01% | 815 |
|
|
2018
Q4 | $5.57M | Buy |
55,279
+52,783
| +2,115% | +$5.94M | 0.01% | 836 |
|
|
2018
Q3 | $319K | Sell |
2,496
-26,463
| -91% | -$3.15M | ﹤0.01% | 1025 |
|
|
2018
Q2 | $3.13M | Sell |
28,959
-1,445
| -5% | -$157K | 0.01% | 640 |
|
|
2018
Q1 | $3.26M | Buy |
30,404
+772
| +3% | +$89.7K | 0.01% | 529 |
|
|
2017
Q4 | $3.47M | Sell |
29,632
-781
| -3% | -$88.3K | 0.01% | 721 |
|
|
2017
Q3 | $3.46M | Sell |
30,413
-2,225
| -7% | -$257K | 0.01% | 696 |
|
|
2017
Q2 | $4.07M | Sell |
32,638
-10,042
| -24% | -$1.19M | 0.01% | 644 |
|
|
2017
Q1 | $5.06M | Buy |
42,680
+7,717
| +22% | +$875K | 0.02% | 572 |
|
|
2016
Q4 | $3.5M | Sell |
34,963
-3,818
| -10% | -$409K | 0.01% | 679 |
|
|
2016
Q3 | $4.89M | Sell |
38,781
-43,766
| -53% | -$5.41M | 0.02% | 589 |
|
|
2016
Q2 | $9.65M | Buy |
82,547
+1,349
| +2% | +$153K | 0.04% | 386 |
|
|
2016
Q1 | $8.41M | Buy |
81,198
+15,264
| +23% | +$1.48M | 0.04% | 404 |
|
|
2015
Q4 | $6.57M | Buy |
65,934
+1,069
| +2% | +$105K | 0.03% | 478 |
|
|
2015
Q3 | $5.92M | Buy |
64,865
+17,976
| +38% | +$1.8M | 0.03% | 496 |
|
|
2015
Q2 | $4.97M | Buy |
46,889
+7,207
| +18% | +$797K | 0.02% | 603 |
|
|
2015
Q1 | $4.53M | Buy |
39,682
+39,146
| +7,303% | +$4.47M | 0.02% | 604 |
|
|
2014
Q4 | $59K | Sell |
536
-1,206
| -69% | -$127K | ﹤0.01% | 1354 |
|
|
2014
Q3 | $170K | Buy |
1,742
+238
| +16% | +$23.4K | ﹤0.01% | 1141 |
|
|
2014
Q2 | $152K | Buy |
1,504
+1,046
| +228% | +$102K | ﹤0.01% | 1096 |
|
|
2014
Q1 | $42K | Buy |
458
+135
| +42% | +$12.4K | ﹤0.01% | 1417 |
|
|
2013
Q4 | $29K | Buy |
323
+99
| +44% | +$8.57K | ﹤0.01% | 1402 |
|
|
2013
Q3 | $18K | Sell |
224
-1,164
| -84% | -$91.6K | ﹤0.01% | 1517 |
|
|
2013
Q2 | $101K | Buy |
+1,388
| New | +$104K | ﹤0.01% | 973 |
|
Other funds holding ZBH
Envestnet Asset Management's ZBH Position: Q2 2026 in Review
Envestnet Asset Management increased its Zimmer Biomet (ZBH) stake by 4% in Q2 2026, buying an estimated $1.03M and bringing the position to 308,571 shares worth $26.6M. The position accounts for 0.01% of the portfolio, ranked #1234.
Envestnet Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.8M in Q1 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Envestnet Asset Management held 308,571 shares of Zimmer Biomet worth $26.6M as of Q2 2026.
- Envestnet Asset Management bought 11,783 Zimmer Biomet shares in Q2 2026, an estimated $1.03M.
- Zimmer Biomet made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1234 holding.
- Envestnet Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Envestnet Asset Management's Zimmer Biomet position peaked at $35.8M in Q1 2025.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.